Dzgoeva, F U <br/><br/>
[Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists].  [electronic resource] 

 -  Terapevticheskii arkhiv  2000 
 - 42-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0040-3660 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Biomarkers--blood<br/>Calcium Channel Blockers--therapeutic use<br/>Chronic Disease<br/>Contrast Media--adverse effects<br/>Coronary Disease--blood<br/>Disease Progression<br/>Drug Hypersensitivity--blood<br/>Epoprostenol--blood<br/>Female<br/>Glomerulonephritis--blood<br/>Humans<br/>Kidney--blood supply<br/>Male<br/>Middle Aged<br/>Renal Circulation--drug effects<br/>Thromboxane A2--blood